+467.0%
MRNA vs FITB
+24.3%
+442.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FITB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.5% | +4.8% | +5.7% |
| 7D | -1.1% | -0.3% | -0.8% | -1.3% |
| 30D | +126.1% | -5.7% | +131.8% | +124.1% |
| 3M | +190.0% | +3.2% | +186.9% | +177.2% |
| 6M | +157.2% | +23.4% | +133.8% | +125.8% |
| YTD | +388.2% | +18.8% | +369.4% | +325.7% |
| 1Y | +467.0% | +25.0% | +442.1% | +359.7% |
| All | +467.0% | +24.3% | +442.7% | +359.7% |
Cumulative growth
Daily Returns
Daily percentage return beside FITB.
Daily Out/Under-Performance
Portfolio return minus FITB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FITB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FITB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling